HU9602286D0 - Desogestrel-containing transdermal application agent - Google Patents

Desogestrel-containing transdermal application agent

Info

Publication number
HU9602286D0
HU9602286D0 HU9602286A HU9602286A HU9602286D0 HU 9602286 D0 HU9602286 D0 HU 9602286D0 HU 9602286 A HU9602286 A HU 9602286A HU 9602286 A HU9602286 A HU 9602286A HU 9602286 D0 HU9602286 D0 HU 9602286D0
Authority
HU
Hungary
Prior art keywords
desogestrel
application agent
transdermal application
containing transdermal
agent
Prior art date
Application number
HU9602286A
Other languages
Hungarian (hu)
Other versions
HUT74458A (en
Inventor
Clemens Guenther
Ralph Lipp
Jutta Riedl
Ulrich Taeuber
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of HU9602286D0 publication Critical patent/HU9602286D0/en
Publication of HUT74458A publication Critical patent/HUT74458A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU9602286A 1994-02-18 1995-02-09 Desogestrel-containing transdermal application agent HUT74458A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4405899A DE4405899A1 (en) 1994-02-18 1994-02-18 Agent for transdermal application containing desogestrel

Publications (2)

Publication Number Publication Date
HU9602286D0 true HU9602286D0 (en) 1996-10-28
HUT74458A HUT74458A (en) 1996-12-30

Family

ID=6511045

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9602286A HUT74458A (en) 1994-02-18 1995-02-09 Desogestrel-containing transdermal application agent

Country Status (10)

Country Link
EP (1) EP0744943A1 (en)
JP (1) JPH09508911A (en)
KR (1) KR970701538A (en)
AU (1) AU1578695A (en)
CA (1) CA2183544A1 (en)
DE (1) DE4405899A1 (en)
HU (1) HUT74458A (en)
NO (1) NO963433L (en)
NZ (1) NZ279226A (en)
WO (1) WO1995022321A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19600347A1 (en) * 1996-01-08 1997-07-10 Lohmann Therapie Syst Lts Skin-adhering pharmaceutical preparation, in particular TTS for the delivery of 17-beta-estradiol to the human organism
FR2749586B1 (en) * 1996-06-11 1998-08-07 Hoechst Marion Roussel Inc NOVEL DEVICES FOR THE TRANSDERMAL ADMINISTRATION OF TRIMEGESTONE, THEIR PREPARATION METHOD AND THEIR APPLICATION AS MEDICAMENTS
DE19629468A1 (en) * 1996-07-11 1998-01-15 Schering Ag Transdermal therapeutic systems
DE19701949A1 (en) * 1997-01-13 1998-07-16 Jenapharm Gmbh Transdermal therapeutic system
AU2223600A (en) * 1999-01-06 2000-07-24 Cedars-Sinai Medical Center Hormone replacement for breast cancer patients
DE10019171A1 (en) * 2000-04-07 2001-10-18 Schering Ag Compositions for use as penetration enhancers in transdermal formulations for highly lipophilic active ingredients
DE102010040299A1 (en) * 2010-09-06 2012-03-08 Bayer Schering Pharma Aktiengesellschaft Transdermal therapeutic systems with crystallization-inhibiting protective film (release liner)
BRPI1003661A2 (en) * 2010-09-15 2013-01-08 Libbs Farmaceutica Ltda pharmaceutical combination to treat and / or prevent fibroid and / or endometriosis, use of resveratrol and progestogen, pharmaceutical composition for treatment and / or prevention of fibroid and / or endometriosis drug for treatment and / or prevention of fibroid and / or endometriosis, kit and Method for the treatment and / or prevention of fibroid and / or endometriosis
US20130195956A1 (en) * 2012-01-27 2013-08-01 Agile Therapeutics, Inc. Transdermal Hormone Delivery

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4210165A1 (en) * 1991-07-30 1993-02-04 Schering Ag TRANSDERMAL THERAPEUTIC SYSTEMS
DE4210711A1 (en) * 1991-10-31 1993-05-06 Schering Ag Berlin Und Bergkamen, 1000 Berlin, De TRANSDERMAL THERAPEUTIC SYSTEMS WITH CRYSTALIZATION INHIBITORS
DE4227989A1 (en) * 1992-08-21 1994-06-09 Schering Ag Agent for transdermal application containing 3-keto-desogestrel
DE4229820C2 (en) * 1992-09-07 1998-12-03 Jenapharm Gmbh Progestogen-based pharmaceutical preparation

Also Published As

Publication number Publication date
CA2183544A1 (en) 1995-08-24
DE4405899A1 (en) 1995-08-24
WO1995022321A1 (en) 1995-08-24
JPH09508911A (en) 1997-09-09
NZ279226A (en) 1998-05-27
KR970701538A (en) 1997-04-12
AU1578695A (en) 1995-09-04
EP0744943A1 (en) 1996-12-04
HUT74458A (en) 1996-12-30
NO963433L (en) 1996-08-16

Similar Documents

Publication Publication Date Title
GB9420657D0 (en) Contrast agents
PL305701A1 (en) Pharmaceutical agent
HUP9800832A3 (en) Transdermal formulation
ZA951232B (en) Contrast agents
HUP9802070A3 (en) Transdermal formulation
GB9402641D0 (en) Therapeutic agents
HU9602286D0 (en) Desogestrel-containing transdermal application agent
GB9411045D0 (en) Compounds and use
IL116999A0 (en) Transdermal formulation
EP1008352A4 (en) Brain-protective agent
EP0799225A4 (en) Compounds and methods
GB9401879D0 (en) Therapeutic agents
EP0935965A4 (en) Antipylori agent
GB9403639D0 (en) Therapeutic agents
ZA965962B (en) Anti-piroplasmotic agent
PL305735A1 (en) Asphalt-epoxy binding agent
PL303744A1 (en) Antocorrosive agent
GB9403333D0 (en) Compound and use
MD823F1 (en) Antimutagenous agent
ZA956704B (en) Antifungal agent
ZW1194A1 (en) Therapeutic agent
GB9406278D0 (en) Therapeutic agent
GB9425739D0 (en) Immunopotentiary agents
GB9411634D0 (en) Use and compounds
GB9401532D0 (en) Anti-microbial agent

Legal Events

Date Code Title Description
DFD9 Temporary prot. cancelled due to non-payment of fee